This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tong, W. L. et al. Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates. Breast Cancer Res. Treat. 173, 167–177 (2019).
Davis, M. M. The evolutionary and structural ‘logic’ of antigen receptor diversity. Semin. Immunol. 16, 239–243 (2004).
Mauro, J. A. & Blanck, G. Functionally distinct gene classes as bigger or smaller transcription factor traps: a possible stochastic component to sequential gene expression programs in cancer. Gene 536, 398–406 (2014).
Clark, K. R. et al. TRB-J1 usage, in combination with the HLA-A*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: Comparisons with microscopic assessments of lymphocyte infiltrates. Int. J. Immunogenet. 46, 31–37 (2019).
Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812–30. (2018).
Chobrutskiy, B. I., Zaman, S., Diviney, A., Mihyu, M. M. & Blanck, G. T-cell receptor-alpha CDR3 domain chemical features correlate with survival rates in bladder cancer. J. Cancer Res. Clin. Oncol. 145, 615–23. (2019).
Bedke, J. & Stenzl, A. Immunotherapeutic strategies for the treatment of renal cell carcinoma: where are we now? Expert Rev. anticancer Ther. 13, 1399–1408 (2013).
Acknowledgements
The authors acknowledge the contributions of USF research computing and the taxpayers of the State of Florida. J.F.A., B.I.C., M.Y., S.F., and J.S.P. are recipients of RISE fellowships from the USF Morsani College of Medicine.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Arturo, J.F., Chobrutskiy, B.I., Yeagley, M. et al. Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival rates. Cell Mol Immunol 17, 776–778 (2020). https://doi.org/10.1038/s41423-019-0328-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41423-019-0328-8
This article is cited by
-
IGL CDR3 Hydropathy and Antigen Chemical Complementarity Associated with Greater Disease-Free Survival in Lung Adenocarcinoma: Implications for Gender Disparities
Biochemical Genetics (2024)
-
Exploiting big data survival information to unify risk-stratification related, adaptive immune receptor parameters for multiple myeloma
Genes & Immunity (2023)
-
Delineation of a T-cell receptor CDR3-cancer mutanome aromaticity factor, assessable via blood samples, that facilitates the establishment of survival distinctions in bladder cancer
Journal of Cancer Research and Clinical Oncology (2023)
-
Adaptive immune receptor features related to breast cancer tissue in Kenyan patients: high immunoglobulin gene expression and high levels of gamma-delta T-cells
Breast Cancer Research and Treatment (2023)
-
Tumor Resident, B-Cell Receptor Chemical Characteristics Associated with Better Overall Survival for Neuroblastoma
Journal of Molecular Neuroscience (2022)